MITOKININ
Summary
Mitokinin is a developer of kinase-targeted neo-substrates intended to treat neurodegenerative and mitochondrial diseases.
Deals Overview
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
Senior Management
Daniel de Roulet
Founder and CEO
Nicholas Hertz
Co-Founder and CSO
Kevan Shokat
Co-Founder